124 related articles for article (PubMed ID: 10089021)
41. Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.
Hatsumi N; Miyawaki S; Yamauchi T; Takeshita A; Komatsu N; Usui N; Arai Y; Ishida F; Morii T; Kano Y; Ogura M; Machida S; Nishii K; Honda S; Ohnishi K; Naoe T;
Int J Hematol; 2019 Apr; 109(4):418-425. PubMed ID: 30725360
[TBL] [Abstract][Full Text] [Related]
42. High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
Schaich M; Parmentier S; Kramer M; Illmer T; Stölzel F; Röllig C; Thiede C; Hänel M; Schäfer-Eckart K; Aulitzky W; Einsele H; Ho AD; Serve H; Berdel WE; Mayer J; Schmitz N; Krause SW; Neubauer A; Baldus CD; Schetelig J; Bornhäuser M; Ehninger G
J Clin Oncol; 2013 Jun; 31(17):2094-102. PubMed ID: 23630210
[TBL] [Abstract][Full Text] [Related]
43. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
Shi P; Zha J; Guo X; Chen F; Fan Z; Huang F; Meng F; Liu X; Feng R; Xu B
Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
[TBL] [Abstract][Full Text] [Related]
44. Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin.
Seipelt G; Hofmann WK; Martin H; Wassmann B; Boehme A; Ottmann OG; Hoelzer D
Ann Hematol; 1998; 76(3-4):145-51. PubMed ID: 9619732
[TBL] [Abstract][Full Text] [Related]
45. D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine.
Kimura S; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Yamasaki R; Ashizawa M; Machishima T; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
Hematology; 2014 Mar; 19(2):107-12. PubMed ID: 23683842
[TBL] [Abstract][Full Text] [Related]
46. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial.
Burnett AK; Russell NH; Hills RK; Hunter AE; Kjeldsen L; Yin J; Gibson BE; Wheatley K; Milligan D
J Clin Oncol; 2013 Sep; 31(27):3360-8. PubMed ID: 23940227
[TBL] [Abstract][Full Text] [Related]
47. Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.
Wang X; Clowes C; Duarte R; Pu QQ
Int J Oncol; 2000 Sep; 17(3):591-5. PubMed ID: 10938403
[TBL] [Abstract][Full Text] [Related]
48. Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.
Malfuson JV; Konopacki J; Thepenier C; Eddou H; Foissaud V; de Revel T
Ann Hematol; 2012 Dec; 91(12):1871-7. PubMed ID: 22820971
[TBL] [Abstract][Full Text] [Related]
49. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH
J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120
[TBL] [Abstract][Full Text] [Related]
50. Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Lyytikäinen O; Elonen E; Lautenschlager I; Jokipii A; Tiittanen L; Ruutu P
Eur J Haematol; 1996 Mar; 56(3):188-9. PubMed ID: 8598243
[No Abstract] [Full Text] [Related]
51. Aspergillus appendicitis in acute myeloid leukaemia.
Rogers S; Potter MN; Slade RR
Clin Lab Haematol; 1990; 12(4):471-6. PubMed ID: 2081387
[No Abstract] [Full Text] [Related]
52. [Improved treatment results in children with AML: Results of study AML-BFM 93].
Creutzig U; Berthold F; Boos J; Fleischhack G; Gadner H; Gnekow A; Graubner U; Henze G; Hermann J; Imbach P; Jürgens H; Kabisch H; Körholz D; Niemeyer CM; Reinhardt D; Reiter A; Ritter J; Spaar HJ; Zimmermann M;
Klin Padiatr; 2001; 213(4):175-85. PubMed ID: 11528551
[TBL] [Abstract][Full Text] [Related]
53. Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor.
Volk J; Kleine HD; Buthmann U; Freund M
Ann Hematol; 2000 Apr; 79(4):187-97. PubMed ID: 10834506
[TBL] [Abstract][Full Text] [Related]
54. Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group.
Dinndorf PA; Avramis VI; Wiersma S; Krailo MD; Liu-Mares W; Seibel NL; Sato JK; Mosher RB; Kelleher JF; Reaman GH
J Clin Oncol; 1997 Aug; 15(8):2780-5. PubMed ID: 9256119
[TBL] [Abstract][Full Text] [Related]
55. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
56. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Tan RM; Quah TC; Aung L; Liang S; Kirk RC; Yeoh AE
Pediatr Blood Cancer; 2007 Mar; 48(3):262-7. PubMed ID: 16602120
[TBL] [Abstract][Full Text] [Related]
57. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
Petti MC; Mandelli F
Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
[No Abstract] [Full Text] [Related]
58. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
[TBL] [Abstract][Full Text] [Related]
59. Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases.
Hanazono Y; Miyazono K; Piao YF; Taketazu F; Chiba S; Miyagawa K; Hirai H; Sakamoto S; Miura Y; Yazaki Y
Int J Hematol; 1992 Jun; 55(3):243-8. PubMed ID: 1379844
[TBL] [Abstract][Full Text] [Related]
60. Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases.
Requena A; Velasco JG; Pinilla J; Gonzalez-Gonzalez A
Eur J Obstet Gynecol Reprod Biol; 1995 Dec; 63(2):139-41. PubMed ID: 8903769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]